Now, scientists can precisely "design" proteins as if they are programming. This is no longer science fiction but a reality being created by the Dutch company Cradle. In the grand tapestry of biotechnology, Cradle's founder, Stefan van Groningen, likens proteins to an "alien programming language." His team is utilizing artificial intelligence to decipher this mysterious language, bringing revolutionary changes to biotechnology. Traditional protein development has been like a long and costly blind exploration. Researchers must go through dozens of experimental rounds, each of which may...

Google DeepMind has released AlphaProteo, an artificial intelligence system focused on generating novel proteins tailored to specific target molecules, aimed at accelerating drug design, disease understanding, and health application research. AlphaProteo successfully designed binders for the protein VEGF-A, which is associated with tumor growth and various disease complications, outperforming traditional methods. Unlike AlphaFold, the proteins designed by this system can interact with biological processes, providing possibilities for developing targeted therapies against harmful proteins.

Dutch-Swiss startup Cradle has successfully raised $240 million, aiming to use AI to help scientists design and engineer proteins faster and more cost-effectively. Cradle employs Generative AI technology, leveraging laboratory data and billions of protein sequences to enhance protein design and accelerate R&D. This technology is expected to address protein engineering challenges that traditional tools cannot handle, providing biopharmaceutical companies with quicker and more successful experimental outcomes. Cradle has attracted Index.